Vital Innovations Holdings Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Vital Innovations Holdings şu anda temettü ödemiyor.

Anahtar bilgiler

Temettü verimi

n/a

Geri Alım Getirisi

Toplam Hissedar Getirisi	n/a
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	HK$0.020
Ödeme oranı	0%

Son temettü ve geri alım güncellemeleri

Güncelleme yok

Recent updates

There's Reason For Concern Over Vital Innovations Holdings Limited's (HKG:6133) Price

Nov 24

Is Vital Innovations Holdings (HKG:6133) A Risky Investment?

Sep 05

Subdued Growth No Barrier To Vital Innovations Holdings Limited's (HKG:6133) Price

Jun 26

Pinning Down Vital Innovations Holdings Limited's (HKG:6133) P/S Is Difficult Right Now

Mar 21

We Think Vital Innovations Holdings (HKG:6133) Has A Fair Chunk Of Debt

Dec 06

Vital Innovations Holdings Limited's (HKG:6133) Subdued P/S Might Signal An Opportunity

Aug 22

What Type Of Returns Would Vital Innovations Holdings'(HKG:6133) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Dec 14

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: 6133 şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: 6133 şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Vital Innovations Holdings Piyasaya Karşı Temettü Getirisi

6133 temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (6133)	0%
Pazarın Alt %25'i (HK)	3.3%
Pazarın En İyi %25'i (HK)	8.1%
Sektör Ortalaması (Tech)	2.6%
Analist tahmini (6133) (3 yıla kadar)	n/a

Önemli Temettü: 6133 şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, 6133 şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: 6133 Hong Kong piyasası için dikkate değer bir temettü ödemiyor.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: 6133 herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Vital Innovations Holdings Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Recent updates

There's Reason For Concern Over Vital Innovations Holdings Limited's (HKG:6133) Price

Less than half of directors are independent

First half 2024 earnings released: CN¥0.011 loss per share (vs CN¥0.01 loss in 1H 2023)

Is Vital Innovations Holdings (HKG:6133) A Risky Investment?

Vital Innovations Holdings Limited to Report First Half, 2024 Results on Aug 29, 2024

Subdued Growth No Barrier To Vital Innovations Holdings Limited's (HKG:6133) Price

Vital Innovations Holdings Limited, Annual General Meeting, Jun 27, 2024

Full year 2023 earnings released: CN¥0.024 loss per share (vs CN¥0.021 loss in FY 2022)

Less than half of directors are independent

Vital Innovations Holdings Limited to Report Fiscal Year 2023 Results on May 16, 2024

Pinning Down Vital Innovations Holdings Limited's (HKG:6133) P/S Is Difficult Right Now

Vital Innovations Holdings Limited to Report Fiscal Year 2023 Final Results on Mar 26, 2024

We Think Vital Innovations Holdings (HKG:6133) Has A Fair Chunk Of Debt

First half 2023 earnings released: CN¥0.01 loss per share (vs CN¥0.01 loss in 1H 2022)

New major risk - Revenue and earnings growth

Vital Innovations Holdings Limited's (HKG:6133) Subdued P/S Might Signal An Opportunity

Vital Innovations Holdings Limited to Report First Half, 2023 Results on Aug 30, 2023

Less than half of directors are independent

Is Vital Innovations Holdings (HKG:6133) Using Debt Sensibly?

First half 2022 earnings released: CN¥0.01 loss per share (vs CN¥0.011 loss in 1H 2021)

Vital Innovations Holdings Limited to Report First Half, 2022 Results on Aug 25, 2022

Less than half of directors are independent

Full year 2021 earnings released: CN¥0.024 loss per share (vs CN¥0.12 loss in FY 2020)

Is Vital Innovations Holdings (HKG:6133) Using Debt In A Risky Way?

Is Vital Innovations Holdings (HKG:6133) Using Debt In A Risky Way?

First half 2021 earnings released: CN¥0.011 loss per share (vs CN¥0.084 loss in 1H 2020)

Full year 2020 earnings released: CN¥0.12 loss per share (vs CN¥0.007 loss in FY 2019)

Vital Innovations Holdings Limited to Report Fiscal Year 2020 Results on Mar 30, 2021

New 90-day low: HK$0.37

Vital Innovations Holdings Limited Announces Appointment of Independent Non-Executive Directors, and Change of Composition of Board Committees

What Type Of Returns Would Vital Innovations Holdings'(HKG:6133) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

New 90-day high: HK$0.35

Vital Innovations Holdings Limited Announces Director and Committee Changes

New 90-day low: HK$0.22

First half earnings released

First half earnings released

New 90-day low - HK$0.29

Vital Innovations Holdings Limited to Report First Half, 2020 Results on Aug 31, 2020

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin